Jordan Clark Buys 117 Shares of Diaceutics (LON:DXRX) Stock

Diaceutics PLC (LON:DXRX) insider Jordan Clark purchased 117 shares of the stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average cost of GBX 128 per share, with a total value of £149.76.

Diaceutics Stock Performance

Shares of DXRX stock opened at GBX 129 on Thursday. The business has a 50-day simple moving average of GBX 152.26 and a 200-day simple moving average of GBX 142.27. The stock has a market cap of £109.17 million, a PE ratio of -71.67 and a beta of 0.58. Diaceutics PLC has a 52-week low of GBX 106 and a 52-week high of GBX 168. The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 0.39.

Diaceutics (LON:DXRX) last issued its quarterly earnings results on Tuesday, September 23rd. The company reported GBX (2.84) earnings per share for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. On average, equities analysts expect that Diaceutics PLC will post 1.0107919 EPS for the current year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.